Compare PCVX & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | PSN |
|---|---|---|
| Founded | 2013 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.3B |
| IPO Year | 2020 | 2019 |
| Metric | PCVX | PSN |
|---|---|---|
| Price | $60.78 | $56.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $88.25 | $79.18 |
| AVG Volume (30 Days) | ★ 1.6M | 984.1K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.77 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $6,364,245,000.00 |
| Revenue This Year | N/A | $5.87 |
| Revenue Next Year | N/A | $7.61 |
| P/E Ratio | ★ N/A | $117.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.10 | $46.88 |
| 52 Week High | $65.00 | $89.50 |
| Indicator | PCVX | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 67.92 | 58.08 |
| Support Level | $42.30 | $48.16 |
| Resistance Level | $64.16 | $59.00 |
| Average True Range (ATR) | 2.56 | 2.38 |
| MACD | 0.95 | 0.60 |
| Stochastic Oscillator | 94.88 | 84.27 |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.